Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427
Revision as of 21:39, 24 June 2020 by Maintenance script (talk | contribs)
Bibliography entry in "COVID-19 pathophysiology: A review" in Clin. Immunol.; 2020 Apr 20 108427; DOI: https://doi.org/10.1016/j.clim.2020.108427
| Title | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial |
|---|---|
| 1st AU | Gautret P |
| 2nd AU | Lagier JC |
| 3rd AU | Hoang VT |
| 4th AU | Meddeb L |
| 5th AU | Mailhe M |
| 6th AU | Doudier B |
| 7th AU | Courjon J |
| 8th AU | Giordanengo V |
| 9th AU | Vieira VE |
| 10th AU | Dupont HT |
| 11th AU | Honore S |
| 12th AU | Colson P |
| PubDate | 2020 |
| Journal | Int J Antimicrob Agents |
| Volume | 105949 |
| Cited In | COVID-19 pathophysiology: A review (DOI: 10.1016/j.clim.2020.108427) |
